CCRN · Musculoskeletal, Neurological, Behavioral/Psychosocial · 7 min read · Open lesson
Acute Ischemic Stroke and Thrombolysis
- Identify rapid assessment priorities, time-sensitive eligibility windows, and vascular screening criteria for patients presenting with acute ischemic stroke.
- Manage hemodynamic targets, post-thrombolytic monitoring intervals, and reperfusion-related complications using evidence-based critical care nursing protocols.
- Apply the AACN Synergy Model competencies to protect stroke patients from aspiration, secondary neurological injury, and hemodynamic compromise.
Triage, Timelines, and Neurological Assessment
In acute ischemic stroke, every critical care decision hinges on establishing an accurate timeline. The foundational reference point is the last known well, which is defined as the time the patient was last observed to be at their baseline neurological state. In the case of wake-up strokes, where a patient awakens with deficits, the last known well must be recorded as the time the patient was last seen normal prior to falling asleep. Last known well anchors standard treatment windows, but eligible patients with wake-up or unknown-onset stroke may still receive imaging-selected reperfusion therapy.
Neurological impairment is quantified using the National Institutes of Health Stroke Scale, which ranges from 0 to 42. A higher score reflects more severe neurological impairment. In the critical care unit, the nurse must maintain continuous vigilance: a rise in the National Institutes of Health Stroke Scale score, particularly by four or more points, or the development of any new neurological deficit warrants immediate reassessment and escalation. Under the AACN Synergy Model, the nurse utilizes Clinical Inquiry to integrate validated tools and evidence into continuous bedside surveillance. It is essential to recognize that posterior circulation strokes can present with vertigo, ataxia, and diplopia, which are deficits under-represented on the standard National Institutes of Health Stroke Scale.
Reperfusion eligibility follows strict clinical timelines. Eligible patients may receive intravenous alteplase within 4.5 hours of last known well under guideline-based criteria; however, eligibility criteria differ between the initial 3 hours and the 3-to-4.5-hour period. Concurrently, endovascular thrombectomy is indicated for eligible patients presenting with large vessel occlusions in the anterior circulation within six hours of last known well. Selected patients with large vessel occlusions may remain eligible for endovascular thrombectomy up to 24 hours after last known well based on clinical findings and advanced imaging selection criteria. A National Institutes of Health Stroke Scale score of six or greater combined with cortical signs strongly raises concern for a large vessel occlusion and warrants prompt vascular imaging, though a lower score does not exclude an occlusion. AACN Collaboration within the interprofessional team ensures a seamless transition when moving an unstable patient from thrombolytic infusion directly to the endovascular intervention suite.
Blood Pressure Targets and Hemodynamic Titration
Hemodynamic management is tightly regulated to balance tissue perfusion against the risk of vascular rupture. Before initiating intravenous thrombolysis, the patient's pre-treatment blood pressure must be below 185 mmHg systolic and below 110 mmHg diastolic. During the infusion and for the entire first 24 hours following intravenous thrombolytic administration, blood pressure must be strictly maintained below 180 mmHg systolic and below 105 mmHg diastolic. To maintain these precise parameters, the critical care nurse administers intravenous labetalol boluses or titrates continuous infusions of nicardipine or clevidipine under provider orders and unit protocols.
Post-thrombolytic monitoring requires structured, intense hemodynamic and neurological surveillance. Blood pressure and neurological assessments are generally performed every 15 minutes for the first 2 hours after starting intravenous thrombolysis, every 30 minutes for the next 6 hours, and hourly for the following 16 hours. Under the AACN Synergy Model, the nurse exercises Clinical Judgment to titrate ordered vasoactive infusions within protocol, actively preventing both breakthrough hypertension and dangerous hypotensive troughs.
Hemodynamic goals differ substantially for patients who do not receive reperfusion therapy. For acute ischemic stroke patients not receiving reperfusion therapy, blood pressure is generally not lowered when it remains below 220/120 mmHg unless another medical condition requires treatment. In these scenarios, the nurse tracks hemodynamic trends and adheres strictly to provider orders and stroke protocols. Lowering blood pressure too rapidly can precipitate cerebral hypoperfusion and cause the ischemic core to expand into the vulnerable penumbra. Similarly, following endovascular thrombectomy, the nurse monitors blood pressure and titrates ordered therapy to the provider-specified target while avoiding hypotension; routine intensive lowering to a systolic pressure below 140 mmHg is not recommended solely because reperfusion was achieved.
| Clinical Scenario | Systolic Target | Diastolic Target | Nursing Considerations |
|---|---|---|---|
| Pre-Treatment (Intravenous Thrombolysis) | < 185 mmHg | < 110 mmHg | Infusion cannot begin until values are reliably below these thresholds. |
| During and First 24 Hours Post-Thrombolysis | < 180 mmHg | < 105 mmHg | Titrate ordered labetalol, nicardipine, or clevidipine to protect the cerebral vasculature. |
| Non-Reperfusion Candidates | < 220 mmHg | < 120 mmHg | Permissive hypertension preserves penumbral perfusion; avoid rapid blood pressure drops. |
| Post-Endovascular Thrombectomy | Provider-specified target | Provider-specified target | Avoid hypotension; routine intensive reduction below 140 mmHg systolic is not recommended solely for reperfusion. |
Reperfusion Complications and Vascular Access Monitoring
The most feared complication of systemic thrombolytic therapy is symptomatic intracranial hemorrhage. Acute neurological decline, sudden severe headache, acute hypertension, or new nausea during a thrombolytic infusion suggests the development of symptomatic intracranial hemorrhage. If any of these signs appear, the nurse's immediate priority is to stop the thrombolytic infusion, promptly notify the stroke team, and prepare the patient for emergent brain imaging. Suspected symptomatic intracranial hemorrhage after thrombolysis requires urgent stroke-team evaluation; provider-directed reversal may include cryoprecipitate to replenish fibrinogen. If cryoprecipitate is unavailable or cannot be administered promptly, the provider may order tranexamic acid or aminocaproic acid for serious post-thrombolysis bleeding.
Another life-threatening complication of thrombolytic therapy is orolingual angioedema. This adverse effect frequently occurs unilaterally and is strongly associated with concurrent angiotensin-converting enzyme inhibitor use. If orolingual angioedema develops during a thrombolytic infusion, the nurse stops the infusion, immediately escalates care, monitors the airway continuously, and prepares for provider-directed treatment and airway intervention.
Post-procedural nursing care after endovascular thrombectomy demands meticulous monitoring of the arterial access site. After femoral-access thrombectomy, the nurse frequently inspects the puncture site for bleeding or hematoma and immediately reports findings suggestive of a vascular complication, such as an expanding mass or a new bruit. The nurse also assesses distal pulses, capillary refill, limb temperature, and motor and sensory function of the accessed extremity at the frequency specified by the postprocedural protocol. The sudden appearance of new flank or back pain accompanied by hypotension and tachycardia raises high concern for retroperitoneal hemorrhage and requires immediate escalation. When radial access is used, the nurse conducts protocol-based assessments of hand perfusion and neurovascular function, promptly reporting any findings concerning for radial artery occlusion or compartment syndrome.
Post-Thrombolytic Precautions and Secondary Injury Prevention
Patient safety during the first 24 hours after thrombolysis requires strict avoidance of secondary hemorrhagic risks. Antiplatelet and anticoagulant medications are generally withheld for the first 24 hours after intravenous thrombolysis, with any exception requiring individualized provider assessment. Before initiating any antithrombotic medications at the end of this window, a follow-up non-contrast head computed tomography or magnetic resonance imaging scan must confirm the absence of hemorrhage. Furthermore, invasive procedures carry an exaggerated bleeding risk; the insertion of nasogastric tubes, indwelling urinary catheters, and arterial lines should be avoided for 24 hours post-thrombolysis unless critically necessary.
Cerebral edema is a prominent cause of secondary neurological decline following large infarctions. Edema after a large ischemic infarction often peaks about 3 to 5 days after stroke onset, although clinically significant deterioration can occur much earlier. In cases of malignant middle cerebral artery infarction, profound swelling can lead to rapid neurological herniation requiring urgent neurosurgical decompression via hemicraniectomy. The critical care nurse tracks subtle neurological transitions: declining consciousness or worsening motor function may serve as early signs of malignant cerebral edema, whereas pupillary asymmetry is a late, ominous sign of impending or active herniation.
Systemic metabolic stability directly influences recovery from ischemic insults. Hyperglycemia is associated with worse outcomes after ischemic stroke; the nurse monitors blood glucose closely and administers ordered treatment, utilizing an intravenous insulin protocol when indicated for a critically ill patient. Similarly, fever is associated with worse clinical outcomes after acute stroke. The critical care nurse monitors temperature, helps investigate and treat fever, and administers ordered antipyretics or selected cooling measures when indicated; routine aggressive cooling solely to maintain strict normothermia has not been shown to improve stroke outcomes.
Aspiration Prevention and AACN Moral Agency
Aspiration pneumonia represents a devastating secondary complication in acute stroke, significantly increasing critical care length of stay, sepsis risk, and overall mortality. Impaired consciousness and severe facial weakness substantially elevate a patient's risk for dysphagia and subsequent aspiration. Patients with suspected acute stroke must remain NPO, including no oral medications, until they pass an appropriate dysphagia screen or a formal swallowing evaluation determines that oral intake is safe.
Before administering any oral food, liquids, or oral medications, a trained registered nurse or other qualified clinician performs a validated dysphagia screen according to local protocol. Depending on the validated tool selected, the nurse-administered screen evaluates key baseline functions, including alertness, the ability to sit upright, facial movement, and tongue movement. During the protocol-based water swallow screen, the nurse provides a specified volume of water and observes closely for coughing, choking, or a wet voice. A wet or gurgly voice or persistent throat clearing after swallowing suggests possible airway penetration or aspiration; however, the nurse must remember that the absence of these signs does not entirely exclude silent aspiration.
If a patient fails any component of the bedside dysphagia screen, the nurse maintains strict non per os status and requests further swallowing evaluation according to the stroke protocol. Under the AACN Synergy Model, the nurse embodies Advocacy and Moral Agency by firmly communicating aspiration risk and refusing to compromise non per os restrictions. It is an absolute safety standard that oral medications must never be crushed and administered in applesauce, pudding, or liquids prior to passing an evidence-based dysphagia screen. If medications are essential, the nurse collaborates with the provider to obtain alternative, non-oral routes.
Common mistakes
- Lowering blood pressure aggressively below 140 mmHg systolic after endovascular thrombectomy simply because successful recanalization was achieved, which risks cerebral hypoperfusion.
- Crushing oral medications into pudding or applesauce for a patient who has not yet passed an evidence-based dysphagia screen or who has failed their swallow evaluation.
- Failing to recognize acute retroperitoneal bleeding following femoral access because the groin site appears clean, missing the critical triad of back or flank pain, hypotension, and tachycardia.
- Relying solely on the absence of coughing or choking during a water swallow challenge to rule out aspiration, which overlooks the possibility of silent aspiration.
Summary
- Last known well marks the time the patient was last seen at baseline, while wake-up strokes use the time the patient was last seen normal prior to falling asleep.
- Intravenous alteplase is administered within 4.5 hours of last known well to eligible patients under guideline criteria, whereas endovascular thrombectomy is indicated within 6 hours for anterior circulation large vessel occlusions and up to 24 hours in selected patients based on advanced imaging.
- Blood pressure must remain below 185/110 mmHg prior to thrombolysis and below 180/105 mmHg during and for 24 hours after infusion, managed via labetalol, nicardipine, or clevidipine.
- For patients not receiving reperfusion therapy, blood pressure is generally not lowered when systolic pressure is below 220 mmHg and diastolic pressure is below 120 mmHg, unless another condition requires treatment; at or above either threshold, follow provider-directed protocols and avoid rapid reduction.
- Symptomatic intracranial hemorrhage demands stopping thrombolytic therapy immediately, notifying the stroke team, obtaining emergent neuroimaging, and preparing provider-directed reversal with cryoprecipitate, or tranexamic acid/aminocaproic acid if cryoprecipitate is delayed or unavailable.
- Patients remain strictly NPO until passing a validated bedside dysphagia screen; crushing medications into food prior to passing is unsafe and prohibited.
- Malignant middle cerebral artery edema often peaks around days 3 to 5 but can cause earlier deterioration; decreasing consciousness requires urgent escalation, while pupillary asymmetry is a late herniation sign, and the neurosurgical team determines candidacy for decompressive hemicraniectomy.
Practice this section
Explained CCRN Musculoskeletal, Neurological, Behavioral/Psychosocial questions, no account needed. CCRN Musculoskeletal, Neurological, Behavioral/Psychosocial practice test
5 practice questions and 20 flashcards for this lesson are in your tests.global account.
Log in to use themThis is an open sample lesson. The full CCRN study guide (58 lessons so far) is included with CCRN plans, together with the practice question bank.
- 1 month
$58.99$29.49 - 3 months
$173.99$86.99 - Lifetime
$350.99$175.49
One payment, no subscription.
See CCRN plansAlready a member? Log in
25 practice questions on this exam
Each CCRN practice test has 25 original questions with the answers explained. No account needed.
Open the CCRN practice testsOriginal lesson written for CCRN practice · updated October 31, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.